Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Novamind Inc (OP: NVMDF ) N/A UNCHANGED Last Price Updated: 3:36 PM EDT, Jun 13, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Novamind Inc < Previous 1 2 Next > Exclusive: New Latin American JV To Provide More Psychedelic Medical Treatments For Mental Health Conditions November 22, 2022 Bienstar Wellness Brasil Ltda., a subsidiary of Bienstar Wellness Corp., has entered into a joint venture agreement with Dr. Sun Clinic, a Brazil-based clinic with more than 30 years of experience... Via Benzinga EXCLUSIVE: Bienstar Wellness Starts Treating Patients With Psychedelic Therapy In Brazil, Acquires BRC Saude Mental July 18, 2022 Zinger Brief The acquisition of BRC Saude Mental & Terapias Assistidas Ltda. provides Bienstar access to the Brazilian market, the largest in Latin America, with a population of 215 million. Ketamine... Via Benzinga Psyched: Elon Musk Tweets About Psychedelics, Numinus Acquires Novamind, Colorado Gov. Signs MDMA Legalization Bill June 15, 2022 Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelics Insider. Via Benzinga New Acquisition: Novamind To Buy Common Shares Of Numinus Pending Canadian Supreme Court Approval June 09, 2022 Numinus Wellness Inc. Via Benzinga Numinus to Acquire Novamind For $20.74M In Stock April 12, 2022 Via Benzinga Novamind Expands To Arizona With Purchase Of New Ketamine Clinic December 23, 2021 Novamind Inc. (Canadian: NM) (OTCQB:NVMDF... Via Benzinga Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company May 24, 2022 Medical Psychedelics have made it into Davos, just in time for the World Economic Forum. Via Benzinga Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress May 19, 2022 After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychotherapy or KAP, for frontline workers, at some of its clinics. Via Benzinga Psyched: Compass, Atai And MindMed Release Q1 Earnings, Phase 3 MDMA Trial Closer To Completion, Enveric Splits Into Two Companies May 17, 2022 The psychedelics space got a new glimpse at the financials of some of its heavy hitters with the release of earnings reports for the first quarter of 2022. Via Benzinga Novamind And Numinus Prepare For Acquisition, Both Companies Share Info Circulars To Shareholders May 11, 2022 June 8, 2022 marks a turning point for both Numinus (OTCQX: NUMIF) and Novamind (OTCQB: NVMDF). Via Benzinga Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward May 02, 2022 The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions. Via Benzinga Novamind To Offer Virtual Mental Health Therapy Sessions May 02, 2022 Novamind (OTCQB: NVMDF), which is to be acquired by Numinus Wellness (OTCMKTS: NUMIF), recently announced a collaboration with health coaching platform HealCommunit Via Benzinga Numinus Wellness Strives To Become Psychedelic Research Hub After Acquisition Of Novamind Inc. April 13, 2022 In a year where M&A activity is expected to ratchet-up in 2022, Numinus Wellness Inc. (OTC: NUMIF) is among the first to take action. Via Benzinga Core One Labs Begins Trading On OTCQB April 06, 2022 Under the CLABF symbol, psychedelics-oriented company Core One Labs (OTCQB: CLABF) started trading on the OTCQB Venture ... Via Benzinga EXCLUSIVE: Bienstar Wellness Enters Brazilian Psychedelic Market, Will Acquire Ibogaine Co. March 29, 2022 Bienstar Wellness Corp., an integrative mental health company specializing in psychedelic medicine with core operations in Latin America, has entered into a binding letter of intent to acquire 100% of... Via Benzinga Novamind To Offer Psychedelic-Assisted Group Therapy March 24, 2022 Novamind Inc. (OTCQB: NVMDF) has announced that it will offer a model of psychedelic-assisted group therapy. Under the name Groups ... Via Benzinga Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study March 22, 2022 The psychedelics space was shaken up on the news thatMindCure Health (OTC: MCURF) was shutting down operations. Via Benzinga Novamind To Host MindMed Phase IIb Trial For LSD Based Drug For Anxiety Treatment March 16, 2022 Novamind Inc. (OTCQB: NVMDF) (CSE:NM) (FSE:HN2) has been selected by Mind Medicine, Inc. (NASDAQ: MNMD)(NEO:MMED) to host ... Via Benzinga Novamind Begins Clinical Trial Of Psilocybin For Depression March 15, 2022 This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Via Benzinga Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial March 15, 2022 A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. UsingReal World ... Via Benzinga Novamind Stock Slightly Up On Grants Restricted Share Units March 11, 2022 Novamind Inc. (OTCQB: NVMDF)(CSE:NM)(FSE:HN2) a mental health company specialized in psychedelic medicine, has granted an ... Via Benzinga Novamind To Conduct Phase II Psilocybin Trial For Major Depressive Disorder March 09, 2022 Novamind Inc. (OTCQB: NVMDF) (CSE:NM)(FSE:HN2) will conduct a phase II clinical trial investigating psilocybin for major ... Via Benzinga Benzinga Expands Footprint into the Psychedelic Industry with the Launch of the Benzinga Psychedelic Advisory Council March 09, 2022 DETROIT, March 4, 2022 /PRNewswire/ -- The Benzinga Psychedelics Advisory Council is a collective of the leading minds and voices in the ... Via Benzinga Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results March 07, 2022 On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances ... Via Benzinga Novamind Posts Record High Revenue Of CA$2.45M, Up 32% QoQ March 02, 2022 Psychedelics-focused mental health company Novamind Inc. (CSE:NM Via Benzinga Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th February 09, 2022 The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,... Via Benzinga Psyched: Psychedelics ETF Launches On NYSE, Psilocybin Trial Approved For Depression, DMT Study Begins February 07, 2022 This week saw new triumphs for public companies in the psychedelics space with the creation of a new ETF tracking the sector, which went public in the NYSE. Via Benzinga Cancer Patients' Case To Use Psilocybin Under Right To Try Law Dismissed By Fed Appeals Court February 01, 2022 As the psychedelics space gains traction on many levels, a number of studies are being conducted to examine whether psychedelic medications can or should be used to treat depression in cancer... Via Benzinga Novamind Stock Dives On $3.95M Private Placement With Institutional Investor January 24, 2022 Novamind Inc. (CSE:NM) (OTCQB: Via Benzinga The Year In Review For Psychedelic Drug Stocks: 2021 December 21, 2021 2021 was two different Via Talk Markets < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.